Q/C Technologies, Inc. Stock-Based Compensation
Q/C Technologies, Inc. (QCLS) reported Stock-Based Compensation of $2.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-12
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.37M, a 2163.77% increase year-over-year.
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $58.61K, a 30.76% decline year-over-year.
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.99M, a 2281.74% increase year-over-year.
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $2.17M, a 105.67% increase from fiscal 2024.
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $1.06M, a 65.33% decline from fiscal 2023.
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $3.05M, a 338.66% increase from fiscal 2022.
- Q/C Technologies, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $695.19K.
| Period end | Share-based Payment Arrangement, Noncash Expense 0 month | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.37M 10-Q · filed 2026-08-12 | $2.43M 10-Q · filed 2026-08-12 | $4.42M derived: sum of 3 quarters · filed 2026-08-12 | $4.42M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $58.61K 10-Q · filed 2026-05-15 | $2.04M derived: sum of 2 quarters · filed 2026-05-15 | $2.04M derived: sum of 3 quarters · filed 2026-05-15 | $2.15M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.99M derived: sum of 2 quarters · filed 2026-04-15 | $2.09M derived: sum of 3 quarters · filed 2026-08-12 | $2.17M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $104.85K derived: sum of 2 quarters · filed 2026-08-12 | $189.49K 10-Q · filed 2025-11-19 | $272.83K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $104.85K 10-Q · filed 2026-08-12 | $189.49K 10-Q · filed 2026-08-12 | $272.83K derived: sum of 3 quarters · filed 2026-08-12 | $286.60K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $84.64K 10-Q · filed 2026-05-15 | $167.98K derived: sum of 2 quarters · filed 2026-05-15 | $181.74K derived: sum of 3 quarters · filed 2026-05-15 | $621.37K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $83.34K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $97.11K derived: sum of 2 quarters · filed 2026-04-15 | $536.73K derived: sum of 3 quarters · filed 2026-04-15 | $1.06M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $13.76K 10-Q · filed 2025-11-19 | $453.39K derived: sum of 2 quarters · filed 2025-11-19 | $973.93K 10-Q · filed 2025-11-19 | $970.75K 10-Q · filed 2024-11-14 | $1.68M derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $439.63K 10-Q · filed 2025-08-19 | $956.99K 10-Q · filed 2025-08-19 | $1.66M derived: sum of 3 quarters · filed 2025-08-19 | $2.26M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | $517.37K 10-Q · filed 2025-05-15 | $1.22M derived: sum of 2 quarters · filed 2025-05-15 | $1.82M derived: sum of 3 quarters · filed 2025-05-15 | $3.50M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $707.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | $1.30M derived: sum of 2 quarters · filed 2025-04-11 | $2.98M derived: sum of 3 quarters · filed 2025-04-11 | $3.05M 10-K · filed 2025-04-11 | ||||
| 2023-09-30 | $595.58K 10-Q · filed 2024-11-14 | $2.27M derived: sum of 2 quarters · filed 2024-11-14 | $2.34M 10-Q · filed 2024-11-14 | $2.46M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.68M 10-Q · filed 2024-08-19 | $1.75M 10-Q · filed 2024-08-19 | $1.86M derived: sum of 3 quarters · filed 2024-08-19 | $2.21M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $69.07K 10-Q · filed 2024-05-15 | $182.60K derived: sum of 2 quarters · filed 2024-05-15 | $535.01K derived: sum of 3 quarters · filed 2024-05-15 | $667.26K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $113.53K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $465.94K derived: sum of 2 quarters · filed 2024-04-01 | $598.19K derived: sum of 3 quarters · filed 2024-04-01 | $695.19K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $352.42K 10-Q · filed 2023-11-14 | $484.66K derived: sum of 2 quarters · filed 2023-11-14 | $581.66K 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | $132.25K 10-Q · filed 2023-08-14 | $229.25K 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | $97.00K 10-Q · filed 2023-05-15 | |||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $15.04M derived: sum of 2 quarters · filed 2022-11-10 | $15.04M 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | $15.04M 10-Q · filed 2022-08-15 | $15.04M 10-Q · filed 2022-08-15 | ||||||
| 2020-12-31 | $567.30K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $840.00K derived: sum of 2 quarters · filed 2022-03-31 | $840.00K derived: sum of 3 quarters · filed 2022-03-31 | $855.00K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $272.70K 10-Q/A · filed 2021-11-15 | $272.70K derived: sum of 2 quarters · filed 2021-11-15 | $287.70K 10-Q/A · filed 2021-11-15 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $7.32K 10-Q · filed 2020-08-14 | ||||||
| 2020-03-31 | $7.32K 10-Q · filed 2020-05-15 | |||||||
| 2019-12-31 | $10.80K 10-K · filed 2020-03-25 | |||||||
| 2018-12-31 | $11.07K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $18.00K derived: sum of 2 quarters · filed 2020-03-25 | $20.74K derived: sum of 3 quarters · filed 2020-03-25 | $12.54K 10-K · filed 2020-03-25 | ||||
| 2018-09-30 | $6.93K 10-Q · filed 2018-11-14 | $9.67K derived: sum of 2 quarters · filed 2018-11-14 | $1.48K 10-Q · filed 2018-11-14 | $13.47K derived: sum of 4 quarters · filed 2019-04-01 | ||||
| 2018-06-30 | $2.74K 10-Q · filed 2018-08-14 | $5.45K 10-Q · filed 2018-08-14 | $6.54K derived: sum of 3 quarters · filed 2019-04-01 | $23.22K derived: sum of 4 quarters · filed 2019-04-01 | ||||
| 2018-04-11 | $5.46K 10-Q · filed 2018-08-14 | |||||||
| 2018-03-31 | $2.71K 10-Q · filed 2018-07-13 | $3.79K derived: sum of 2 quarters · filed 2019-04-01 | $20.48K derived: sum of 3 quarters · filed 2019-04-01 | $27.75K derived: sum of 4 quarters · filed 2019-04-01 | ||||
| 2017-12-31 | $1.08K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $17.77K derived: sum of 2 quarters · filed 2019-04-01 | $25.04K derived: sum of 3 quarters · filed 2019-04-01 | $5.46K 10-K · filed 2019-04-01 | $19.46K 10-K · filed 2018-04-03 | |||
| 2017-09-30 | $16.68K 10-Q · filed 2018-11-14 | $4.37K 10-Q · filed 2017-11-14 | $23.96K derived: sum of 2 quarters · filed 2018-11-14 | $4.37K 10-Q · filed 2018-11-14 | $16.68K 10-Q · filed 2017-11-14 | $34.15K derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $7.28K 10-Q · filed 2018-08-14 | $12.37K 10-Q · filed 2018-08-14 | $17.46K derived: sum of 3 quarters · filed 2018-08-14 | $55.72K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $5.04K 10-Q · filed 2018-07-13 | $10.19K derived: sum of 2 quarters · filed 2018-07-13 | $48.45K derived: sum of 3 quarters · filed 2018-07-13 | |||||
| 2016-12-31 | $5.15K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13 | $43.41K derived: sum of 2 quarters · filed 2018-07-13 | $51.65K 10-K/A · filed 2018-07-13 | |||||
| 2016-09-30 | $38.26K 10-Q/A · filed 2018-07-13 | $46.50K 10-Q/A · filed 2018-07-13 | ||||||
| 2015-12-31 | $52.36K 10-K · filed 2017-04-11 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $549.60K 10-K · filed 2015-03-23 | ||||||
| 2014-09-30 | $549.60K 10-Q · filed 2014-11-13 | |||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |